Economic value of influenza vaccination

Chiara De Waure, Maria Assunta Veneziano, Chiara Cadeddu, Silvio Capizzi, Maria Lucia Specchia, Stefano Capri, Walter Ricciardi

Research output: Contribution to journalArticle

17 Citations (Scopus)


Influenza epidemics are responsible for high mortality and morbidity rates in particular among elderly and high risk groups. This review is aimed at assessing the economic value of vaccination in these groups. A search of full economic evaluations of influenza vaccination in comparison with no interventions was performed on PubMed from January 1990 to May 2011. Only economic evaluations dealing with elderly and high risk groups were considered. The quality of selected articles was assessed through Drummond's checklist. Sixteen cost-effectiveness analyses and four cost-benefit analyses were included: overall, the quality of studies was fairly good. The vaccination was demonstrated to be cost-effective or cost-saving in almost all studies, independently by the perspective and the type of analysis. Influenza vaccination is a worthwhile intervention from the pharmacoeconomic view-point, anyway a standardization of methods should be desirable in order to guarantee the comparability and transferability of results.
Original languageEnglish
Pages (from-to)119-129
Number of pages11
Publication statusPublished - 2012


  • Economic evaluation
  • Influenza
  • Vaccine


Dive into the research topics of 'Economic value of influenza vaccination'. Together they form a unique fingerprint.

Cite this